Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation

Pharmacological Reviews

Volumn 56, Issue 1, 2004, Pages 1-29

  Catania, Anna ^a   Gatti, Stefano ^a   Colombo, Gualtiero ^a   Lipton, James M ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Zengen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; AGOUTI PROTEIN; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ANTIINFLAMMATORY AGENT; BETA ENDORPHIN; BETA INTERMEDIN; BETA LIPOTROPIN; CORTICOTROPIN; CORTICOTROPIN DERIVATIVE; CORTICOTROPIN[1-17]; CORTICOTROPIN[1-39]; CORTICOTROPIN[18-39]; CORTICOTROPIN[4-10]; GAMMA INTERMEDIN; GAMMA LIPOTROPIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOTROPIN; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR STIMULATING AGENT; PROOPIOMELANOCORTIN; RECEPTOR SUBTYPE; TETRACOSACTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; AUTOIMMUNE DISEASE; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; ENCEPHALITIS; ENTERITIS; GENE EXPRESSION; GOUT; HEMORRHAGIC SHOCK; INFECTION; INFLAMMATION; ISCHEMIA; NONHUMAN; ORGAN TRANSPLANTATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN PROCESSING; REPERFUSION INJURY; RESPIRATORY DISTRESS SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; STRUCTURE ACTIVITY RELATION; SYSTEMIC VASCULITIS; UVEORETINITIS;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; PRO-OPIOMELANOCORTIN; RECEPTORS, MELANOCORTIN;

EID: 1542347163     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.56.1.1     Document Type: Review

References (363)

1. Abdel-Malek Z, Scott MC, Suzuki I, Tada A, Im S, Lamoreux L, Ito S, Barsh G, and Hearing VJ (2000) The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 13 (Suppl 8):156-162.
2. Abdel-Malek Z, Swope VB, Suzuki I, Akcali C, Harriger MD, Boyce ST, Urabe K, and Hearing VJ (1995) Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 92:1789-1793.
3. Abdel-Malek ZA (2001) Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58:434-441.
4. Abou-Mohamed G, Papapetropoulos A, Ulrich D, Catravas JD, Tuttle RR, and Caldwell RW (1995) HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro. J Pharmacol Exp Ther 275:584-591.
5. Adachi S, Morii E, Kim D, Ogihara H, Jippo T, Ito A, Lee YM, and Kitamura Y (2000) Involvement of mi-transcription factor in expression of α-melanocyte-stimulating hormone receptor in cultured mast cells of mice. J Immunol 164:855-860.
6. Adan RA, van der Kraan M, Doornbos RP, Bar PR, Burbach JP, and Gispen WH (1996) Melanocortin receptors mediate α-MSH-induced stimulation of neurite outgrowth in neuro 2A cells. Brain Res Mol Brain Res 36:37-44.
7. Adan RA and Vink T (2001) Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders. Eur Neuropsychopharmacol 11:483-490.
8. Airaghi L, Capra R, Pravettoni G, Maggiolo F, Suter F, Lipton JM, and Catania A (1999) Elevated concentrations of plasma α-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. J Lab Clin Med 133:309-315.
9. Airaghi L, Garofalo L, Cutuli MG, Delgado R, Carlin A, Demitri MT, Badalamenti S, Graziani G, Lipton JM, and Catania A (2000) Plasma concentrations of α-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. Nephrol Dial Transplant 15:1212-1216.
10. Airaghi L, Lettino M, Manfredi MG, Lipton JM, and Catania A (1995) Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J 130:204-211.
11. Akbulut S, Byersdorfer CA, Larsen CP, Zimmer SL, Humphreys TD, and Clarke BL (2001) Expression of the melanocortin 5 receptor on rat lymphocytes. Biochem Biophys Res Commun 281:1086-1092.
12. Al-Obeidi F, Castrucci AM, Hadley ME, and Hruby VJ (1989) Potent and prolonged acting cyclic lactam analogues of α-melanotropin: design based on molecular dynamics. J Med Chem 32:2555-2561.
13. Altavilla D, Bazzani C, Squadrito F, Cainazzo MM, Mioni C, Bertolini A, and Guarini S (2000) Adrenocorticotropin inhibits nitric oxide synthase II mRNA expression in rat macrophages. Life Sci 66:2247-2254.
14. Altavilla D, Cainazzo MM, Squadrito F, Guarini S, Bertolini A, and Bazzani C (1998) Tumour necrosis factor-α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat. Br J Pharmacol 124:1587-1590.
15. Alvaro JD, Tatro JB, Quillan JM, Fogliano M, Eisenhard M, Lerner MR, Nestler EJ, and Duman RS (1996) Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol 50:583-591.
16. Antonawich FJ, Azmitia EC, Kramer HK, and Strand FL (1994) Specificity versus redundancy of melanocortins in nerve regeneration. Ann NY Acad Sci 739:60-73.
17. Aoki H and Moro O (2002) Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 71:2171-2179.
18. Artuc M, Grutzkau A, Luger T, and Henz BM (1999) Expression of MC1- and MC5-receptors on the human mast cell line HMC-1. Ann NY Acad Sci 885:364-367.
19. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, Barsh GS, and Watson SJ (1999) Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 19:RC26.
20. Bar PR, Hol EM, and Gispen WH (1993) Trophic effects of melanocortins on neuronal cells in culture. Ann NY Acad Sci 692:284-286.
21. Barcellini W, Colombo G, La Maestra L, Clerici G, Garofalo L, Brini AT, Lipton JM, and Catania A (2000) α-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. J Leukoc Biol 68:693-699.
22. Bazzani C, Guarini S, Botticelli AR, Zaffe D, Tomasi A, Bini A, Cainazzo MM, Ferrazza G, Mioni C, and Bertolini A (2001) Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 297:1082-1087.
23. Bazzani C, Mioni C, Ferrazza G, Cainazzo MM, Bertolini A, and Guarini S (2002) Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury. Resuscitation 52:109-115.
24. Becher E, Mahnke K, Brzoska T, Kalden DH, Grabbe S, and Luger TA (1999) Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann NY Acad Sci 885:188-195.
25. Beck B (2000) Neuropeptides and obesity. Nutrition 16:916-923.
26. Beckwith BE, Sandman CA, Hothersall D, and Kastin AJ (1977) Influence of neonatal injections of α-MSH on learning, memory and attention in rats. Physiol Behav 18:63-71.
27. Beckwith BE, Tinius TP, Hruby VJ, al-Obeidi F, Sawyer TK, and Affholter JA (1989) The effects of structure-conformation modifications of melanotropin analogs on learning and memory: D-amino acid substituted linear and cyclic analogs. Peptides 10:361-368.
28. Bell RC and Lipton JM (1987) Pulsatile release of antipyretic neuropeptide α-MSH from septum of rabbit during fever. Am J Physiol 252:R1152-R1157.
29. Benjannet S, Rondeau N, Day R, Chretien M, and Seidah NG (1991) PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88:3564-3568.
30. Bertagna X, Lenne F, Comar D, Massias JF, Wajcman H, Baudin V, Luton JP, and Girard F (1986) Human β-melanocyte-stimulating hormone revisited. Proc Natl Acad Sci USA 83:9719-9723.
31. Bertagna X, Nicholson WE, Sorenson GD, Pettengill OS, Mount CD, and Orth DN (1978) Corticotropin, lipotropin and β-endorphin production by a human non-pituitary tumor in culture: evidence for a common precursor. Proc Natl Acad Sci USA 75:5160-5164.
32. Bertolini A, Guarini S, Rompianesi E, and Ferrari W (1986) A-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur J Pharmacol 130:19-26.
33. Beuschlein F and Hammer GD (2002) Ectopic pro-opiomelanocortin syndrome. Endocrinol Metab Clin North Am 31:191-234.
34. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T, Scholzen T, and Luger TA (1997) Evidence for the differential expression of the functional α-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol 158:3378-3384.
35. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, and Luger TA (1996) Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 156:2517-2521.
36. Bijlsma WA, Schotman P, Jennekens FG, Gispen WH, and De Wied D (1983) The enhanced recovery of sensorimotor function in rats is related to the melanotropic moiety of ACTH/MSH neuropeptides. Eur J Pharmacol 92:231-236.
37. Bitensky MW and Burstein SR (1965) Effects of cyclic adenosine monophosphate and melanocyte-stimulating hormone on frog skin in vitro. Nature (Lond) 208:1282-1284.
38. Blalock JE (1985) Pro-opiomelanocortin-derived-peptides in the immune system. Clin Endocrinol 22:823-827.
39. Blalock JE (1999) Proopiomelanocortin and the immune-neuroendocrine connection. Ann NY Acad Sci 885L:161-172.
40. Blanchard SG, Harris CO, Ittoop OR, Nichols JS, Parks DJ, Truesdale AT, and Wilkison WO (1995) Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. Biochemistry 34:10406-10411.
41. Bohm M and Luger TA (2000) The role of melanocortins in skin homeostasis. Horm Res (Basel) 54:287-293.
42. Bohm M, Metze D, Schulte U, Becher E, Luger TA, and Brzoska T (1999a) Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol 8:453-461.
43. Bohm M, Schulte U, Kalden H, and Luger TA (1999b) Alpha-melanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann NY Acad Sci 885:277-286.
44. Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61-92.
45. Boston BA (1999) The role of melanocortins in adipocyte function. Ann NY Acad Sci 885:75-84.
46. Boston BA (2001) Pro-opiomelanocortin and weight regulation: from mice to men. J Pediatr Endocrinol Metab 14 (Suppl 6):1409-1416.
47. Boston BA and Cone RD (1996) Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137:2043-2050.
48. Bravenboer B, Hendrikse PH, Oey PL, van Huffelen AC, Groenhout C, Gispen WH, and Erkelens DW (1994) Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy. Diabetologia 37:408-413.
49. Bravenboer B, Kappelle AC, van Buren T, Erkelens DW, and Gispen WH (1993) ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetol 30:21-24.
50. Broberger C, Johansen J, Johansson C, Schalling M, and Hokfelt T (1998) The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048.
51. Bruinink A and Birchler F (1993) Effects of cisplatin and ORG.2766 in chick embryonic brain cell cultures. Arch Toxicol 67:325-329.
52. Brzoska T, Kalden D, Fastrich M, Moller M, Schioth HB, Wikberg J, and Luger T (1999a) Two new α-melanocyte stimulating hormone (α-MSH) analogues (MS05 and MS09) are potent immunomodulators in vivo and in vitro. J Investig Dermatol 113:482.
53. Brzoska T, Kalden DH, Scholzen T, and Luger TA (1999b) Molecular basis of the α-MSH/IL-1 antagonism. Ann NY Acad Sci 885:230-238.
54. Buckley DI and Ramachandran J (1981) Characterization of corticotropin receptors on adrenocortical cells. Proc Natl Acad Sci USA 78:7431-7435.
55. Buggy JJ (1998) Binding of α-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J 331:211-216.
56. Bultman SJ, Michaud EJ, and Woychik RP (1992) Molecular characterization of the mouse agouti locus. Cell 71:1195-1204.
57. Busca R and Ballotti R (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13:60-69.
58. Cammas FM, Pullinger GD, Barker S, and Clark AJ (1997) The mouse adrenocorticotropin receptor gene: cloning and characterization of its promoter and evidence for a role for the orphan nuclear receptor steroidogenic factor 1. Mol Endocrinol 11:867-876.
59. Cannon JG, Tatro JB, Reichlin S, and Dinarello CA (1986) α melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137:2232-2236.
60. Catania A, Airaghi L, Colombo G, and Lipton JM (2000a) Alpha-melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol Metab 11:304-308.
61. Catania A, Airaghi L, Garofalo L, Cutuli M, and Lipton JM (1998a) The neuropeptide α-MSH in HIV infection and other disorders in humans. Ann NY Acad Sci 840: 848-856.
62. Catania A, Airaghi L, Manfredi MG, Vivirito MC, Milazzo F, Lipton JM, and Zanussi C (1993) Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 66:73-79.
63. Catania A, Arnold J, Macaluso A, Hiltz ME, and Lipton JM (1991) Inhibition of acute inflammation in the periphery by central action of salicylates. Proc Natl Acad Sci USA 88:8544-8547.
64. Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, and Gattinoni L (2000b) Plasma concentrations and anti-L-cytokine effects of, α-melanocyte stimulating hormone in septic patients. Crit Care Med 28:1403-1407.
65. Catania A, Cutuli M, Garofalo L, Carlin A, Airaghi L, Barcellini W, and Lipton JM (2000c) The neuropeptide α-MSH in host defense. Ann NY Acad Sci 917:227-231.
66. Catania A, Garofalo L, Cutuli M, Gringeri A, Santagostino E, and Lipton JM (1998b) Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients. Peptides 19:1099-1104.
67. Catania A, Gatti S, Colombo G, and Lipton JM (2003) α-Melanocyte stimulating hormone in modulation of inflammatory reactions. Pediat Endocrinol Rev 1:101-108.
68. Catania A, Gerloni V, Procaccia S, Airaghi L, Manfredi MG, Lomater C, Grossi L, and Lipton JM (1994a) The anticytokine neuropeptide α-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1:321-328.
69. Catania A and Lipton JM (1993) α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 14:564-576.
70. Catania A, Manfredi MG, Airaghi L, Ceriani G, Gandino A, and Lipton JM (1994b) Cytokine antagonists in infectious and inflammatory disorders. Ann NY Acad Sci 741:149-161.
71. Catania A, Manfredi MG, Airaghi L, Vivirito MC, Capetti A, Milazzo F, Lipton JM, and Zanussi C (1994c) Plasma concentration of cytokine antagonists in patients with HIV infection. Neuroimmunomodulation 1:42-49.
72. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, and Lipton JM (1996) The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17:675-679.
73. Catania A, Suffredini AF, and Lipton JM (1995) Endotoxin causes release of α-melanocyte-stimulating hormone in normal human subjects. Neuroimmunomodulation 2:258-262.
74. Cavaletti G, Cascinu S, Venturino P, Tedeschi M, and Tredici G (1996) Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Res 16:3149-3159.
75. Ceriani G, Diaz J, Murphree S, Catania A, and Lipton JM (1994a) The neuropeptide α-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1:28-32.
76. Ceriani G, Macaluso A, Catania A, and Lipton JM (1994b) Central neurogenic anti-inflammatory action of α-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59:138-143.
77. Chakraborty AK, Funasaka Y, Pawelek JM, Nagahama M, Ito A, and Ichihashi M (1999) Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Investig Dermatol 112:853-860,
78. Chakraborty AK, Funasaka Y, Slominski A, Ermak G, Hwang J, Pawelek JM, and Ichihashi M (1996) Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1313:130-138.
79. Chang ACY, Cochet M, and Cohen SN (1980) Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide. Proc Natl Acad Sci USA 77:4890-4894.
80. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vorgs A, Feng Y, Cao L, et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102.
81. Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, and Cone RD (1997) Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91:789-798.
82. Chhajlani V (1996) Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38:73-80.
83. Chhajlani V, Muceniece R, and Wikberg JE (1993) Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 195:866-873.
84. Chhijlani V and Wikberg JE (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309:417-420.
85. Chiao H, Foster S, Thomas R, Lipton J, and Star RA (1996) Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Investig 97:2038-2044.
86. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, and Star RA (1997) Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Investig 99:1165-1172.
87. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, and Star RA (1998) Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 54:765-774.
88. Colombo G, Buffa R, Bardella MT, Garofalo L, Carlin A, Lipton JM, and Catania A (2002) Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10:208-216.
89. Cone RD (2000) The Melanocortin Receptors, Humana Press, Totowa, NJ.
90. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, and Low MJ (2001) The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25 (Suppl 5):S63-S67.
91. Crowley VE, Yeo GS, and O'Rahilly S (2002) Obesity therapy: altering the energy intake-and-expenditure balance sheet. Nat Rev Drug Discov 1:276-286.
92. Cutuli M, Cristiani S, Lipton JM, and Catania A (2000) Antimicrobial effects of α-MSH peptides. J Leukoc Biol 67:233-239.
93. Datta PC and King MG (1982) Alpha-melanocyte-stimulating hormone and behavior. Neurosci Biobehav Rev 6:297-310.
94. Davidson J, Milton AS, and Rotondo D (1992) Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit. J Physiol (Lond) 451:491-502.
95. Day R, Schafer MK, Watson SJ, Chretien M, and Seidah NG (1992) Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol 6:485-497.
96. Daynes RA, Robertson BA, Cho BH, Burnham DK, and Newton R (1987) Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. J Immunol 139:103-109.
97. de Angelis E, Sahm UG, Ahmed AR, Olivier GW, Notarianni LJ, Branch SK, Moss SH, and Pouton CW (1995) Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture. Microvasc Res 50:25-34.
98. Deeter LB, Martin LW, and Lipton JM (1989) Antipyretic properties of centrally administered α-MSH fragments in the rabbit. Peptides 9:1285-1288.
99. Dekker AJ (1988) Effect of α-melanocyte-stimulating hormone on peripheral nerve regeneration in the rat: histological aspects and comparison with the effect of gangliosides. Exp Neurol 99:490-497.
100. de Koning P, Neijt JP, Jennekens FG, and Gispen WH (1987) Org.2766 protects from cisplatin-induced neurotoxicity in rats. Exp Neurol 97:746-750.
101. Delgado Hernandez R, Demitri MT, Carlin A, Meazza C, Villa P, Ghezzi P, Lipton JM, and Catania A (1999) Inhibition of systemic inflammation by central action of the neuropeptide α-melanocyte-stimulating hormone. Neuroimmunomodulation 6:187-192.
102. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron P, Lipton JM, and Catania A (1998) Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 63:740-745.
103. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, and Star RA (2001) Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 60:2118-2128.
104. Dinulescu DM and Cone RD (2000) Agouti and agouti-related protein: analogies and contrasts. J Biol Chem 275:6695-6698.
105. Dixon HBF (1960) Chromatographic isolations of pig and human melanocyte stimulating hormones. Biochim Biophys Acta 37:38-42.
106. Drouin J and Goodman HM (1980) Most of the coding region of rat ACTH/β-LPH precursor gene lacks intervening sequences. Nature (Lond) 288:610-613.
107. Eberle A (1988) The Melanotropins, Karger, Basel, Switzerland.
108. Eberle A, Kriwaczek VM, and Schwyzer R (1978) Mechanism of α-melanotropin action. Bull Schweiz Akad Med Wiss 34:99-111.
109. Edwards PM, Kuiters RR, Boer GJ, and Gispen WH (1986) Recovery from peripheral nerve transection is accelerated by local application of α-MSH by means of microporous Accurel polypropylene tubes. J Neurol Sci 74:171-176.
110. Edwards PM, Van der Zee CE, Verhaagen J, Schotman P, Jennekens FG, and Gispen WH (1984) Evidence that the neurotrophic actions of α-MSH may derive from its ability to mimick the actions of a peptide formed in degenerating nerve stumps. J Neurol Sci 64:333-340.
111. Elmquist JK, Elias CF, and Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221-232.
112. Entwistle ML, Hann LE, Sullivan DA, and Tatro JB (1990) Characterization of functional melanotropin receptors in lacrimal glands of the rat. Peptides 11:477-483.
113. Etemad-Moghadam B, Chen H, Yin P, Aziz N, and Hedley ML (2002) Inhibition of NF-κB activity by plasmid expressed αMSH peptide. J Neuroimmunol 125:23-29.
114. Farooqui JZ, Medrano EE, Boissy RE, Tigelaar RE, and Nordlund JJ (1995) Thy-1+ dendritic cells express truncated form of POMC mRNA. Exp Dermatol 4:297-301.
115. Fathi Z, Iben LG, and Parker EM (1995) Cloning, expression and tissue distribution of a fifth melanocortin receptor subtype. Neurochem Res 20:107-113.
116. Feinberg MB (1992) The molecular biology and pathogenesis of HIV-1 infection. Curr Opin Infect Dis 5:214-220.
117. Feng JD, Dao T, and Lipton JM (1987) Effects of preoptic microinjections of α-MSH on fever and normal temperature control in rabbits. Brain Res Bull 18:473-477.
118. Fotsch C, Smith DM, Adams JA, Cheetham J, Croghan M, Doherty EM, Hale C, Jarosinski MA, Kelly MG, Norman MH, et al. (2003) Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-DPhe-Arg-Trp-Lys]-NH(2). Bioorg Med Chem Lett 13:2337-2340.
119. Fox JA and Kraicer J (1981) Immunoreactive α melanocyte stimulating hormone, its distribution in the gastrointestinal tract of intact and hypophysectomized rats. Life Sci 28:2127-2132.
120. Galimberti D, Baron P, Meda L, Prat E, Scarpini E, Delgado R, Catania A, Lipton JM, and Scarlato G (1999) α-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-α by microglial cells activated with β-amyloid and interferon γ. Biochem Biophys Res Commun 263:251-256.
121. Gandara DR, Perez EA, Weibe V, and De Gregorio MW (1991) Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity. Semin Oncol 18:49-55.
122. Gantz I and Fong TM (2003) The melanocortin system. Am J Physiol Endocrinol Metab 284:E468-E474.
123. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, and Yamada T (1993a) Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246-8250.
124. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, and Yamada T (1993b) Molecular cloning, expression and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174-15179.
125. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, and Yamada T (1994) Molecular cloning, expression and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200:1214-1220.
126. Gatti S, Colombo G, Buffa R, Turcatti F, Garofalo L, Carboni N, Ferla L, Fassati LR, Lipton JM, and Catania A (2002) α-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation (Baltim) 74: 1678-1684.
127. Gerritsen van der Hoop R, de Koning P, Boven E, Neijt JP, Jennekens FG, and Gispen WH (1988) Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. Eur J Cancer Clin Oncol 24:637-642.
128. Gerritsen van der Hoop R, Hamers FP, Neijt JP, Veldman H, Gispen WH, and Jennekens FG (1994) Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence. J Neurol Sci 126:109-115.
129. Gerst JE and Salomon Y (1988) A synthetic analog of the calmodulin-binding domain of myosin light chain kinase inhibits melanotropin receptor function and activation of adenylate cyclase. J Biol Chem 263:7073-7078.
130. Gerst JE, Sole J, and Salomon Y (1987) Dual regulation of β-melanotropin receptor function and adenylate cyclase by calcium and guanosine nucleotides in the M2R melanoma cell line. Mol Pharmacol 31:81-88
131. Getting SJ (2002) Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends Pharmacol Sci 23:447-449.
132. Getting SJ, Allcock GH, Flower R, and Perretti M (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 69:98-104.
133. Getting SJ, Christian HC, Flower RJ, and Perretti M (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46:2765-2775.
134. Getting SJ, Christian HC, Lam CW, Gavins FN, Flower RJ, Schioth HB, and Perretti M (2003a) Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol 170: 3323-3330.
135. Getting SJ, Gibbs L, Clark AJ, Flower RJ, and Perretti M (1999) POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162:7446-7453.
136. Getting SJ and Perretti M (2000) MC3-R as a novel target for antiinflammatory therapy. Drug News Perspect 13:19-27.
137. Getting SJ, Schioth HB, and Perretti M (2003b) Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) α -melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther 306:631-637.
138. Gispen WH, Hamers FP, Vecht CJ, Jennekens FG, and Neyt JP (1992) ACTH/ MSH like peptides in the treatment of cisplatin neuropathy. J Steroid Biochem Mol Biol 43:179-183.
139. Glyn JR and Lipton JM (1981) Hypothermic and antipyretic effects of centrally administered ACTH(1-24) and α-melanotropin. Peptides 2:177-187.
140. Glyn-Ballinger JR, Bernardini GL, and Lipton JM (1983) α-MSH injected into the septal region reduces fever in rabbits. Peptides 4:199-203.
141. Goelst K, Mitchell D, and Laburn H (1991) Effects of α-melanocyte stimulating hormone on fever caused by endotoxin in rabbits. J Physiol (Lond) 441:469-476.
142. Goodfellow VS and Saunders J (2003) The melanocortin system and its role in obesity and cachexia. Curr Top Med Chem 3:855-883.
143. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, and Luger TA (1996) α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156:473-478.
144. Grieco P, Balse PM, Weinberg D, MacNeil T, and Hruby VJ (2000) D-Amino acid scan of γ-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem 43:4998-5002.
145. Grieco P, Balse-Srinivasan P, Han G, Weinberg D, MacNeil T, Van der Ploeg LH, and Hruby VJ (2002) Synthesis and biological evaluation on hMC3, hMC4 and hMC5 receptors of γ-MSH analogs substituted with L-alanine. J Pept Res 59:203-210.
146. Grieco P, Rossi C, Colombo G, Gatti S, Novellino E, Lipton JM, and Catania A (2003) Novel α-melanocyte stimulating hormone peptide analogues with high candidacidal activity. J Med Chem 46:850-855.
147. Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz JC, and Sokoloff P (1994) Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem Biophys Res Commun 200:1007-1014.
148. Guarini S, Bazzani C, Cainazzo MM, Mioni C, Ferrazza G, Vergoni AV, Schioth HB, Wikberg JE, and Bertolini A (1999) Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J Pharmacol Exp Ther 291:1023-1027.
149. Guarini S, Schioth HB, Mioni C, Cainazzo M, Ferrazza G, Giuliani D, Wikberg JE, Bertolini A, and Bazzani C (2002) MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias. Naunyn Schmiedeberg's Arch Pharmacol 366:177-182.
150. Gupta AK, Diaz RA, Higham S, and Kone BC (2000) α-MSH inhibits induction of C/EBP/β-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int 57:2239-2248.
151. Haddad JJ, Lauterbach R, Saade NE, Safieh-Garabedian B, and Land SC (2001) A-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation: evidence for involvement of an interleukin-1β193-195 receptor antagonism in the alveolar epithelium. Biochem J 355:29-38.
152. Hadley ME and Haskell-Luevano C (1999) The proopiomelanocortin system. Ann NY Acad Sci 885:1-21.
153. Hadley ME, Hruby VJ, Blanchard J, Dorr RT, Levine N, Dawson BV, al-Obeidi F, and Sawyer TK (1998) Discovery and development of novel melanogenic drugs. Melanotan-I and -II. Pharm Biotechnol 11:575-595.
154. Hamers F, Neijt J, and Gispen W (1992) Protection of cisplatin-induced neuropathy: recent developments. Pathol Biol 39:829-830.
155. Hamers FP, Pette C, Neijt JP, and Gispen WH (1993) The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats. Eur J Pharmacol 233:177-178.
156. Han G, Quillan JM, Carlson K, Sadee W, and Hruby VJ (2003) Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist. J Med Chem 46:810-819.
157. Hancock RE (1997) Peptide antibiotics. Lancet 349:418-422.
158. Hancock RE (2001) Cationic peptides: effectors in innate immunity and novel anti-microbials. Lancet Infect Dis 1:156-164.
159. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjoorbaek C, Elmquist JK, Flier JS, and Hollenberg AN (2001) Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Investig 107:111-120.
160. Hartmeyer M, Scholzen T, Becher E, Bhardwaj RS, Schwarz T, and Luger TA (1997) Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with α-melanocyte-stimulating hormone. J Immunol 159:1930-1937.
161. Haskell-Luevano C, Hendrata S, North C, Sawyer TK, Hadley ME, Hruby VJ, Dickinson C, and Gantz I (1997) Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. J Med Chem 40:2133-2139.
162. Haskell-Luevano C, Sawyer TK, Trumpp-Kallmeyer S, Bikker JA, Humblet C, Gantz I, and Hruby VJ (1996) Three-dimensional molecular models of the hMCIR melanocortin receptor: complexes with melanotropin peptide agonists. Drug Des Discov 14:197-211.
163. Hassoun HT, Zou L, Moore FA, Kozar RA, Weisbrodt NW, and Kone BC (2002) Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 282: G1059-G1068.
164. Haycock JW, Rowe SJ, Cartledge S, Wyatt A, Ghanem G, Morandini R, Rennie IG, and MacNeil S (2000) Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem 275:15629-15636.
165. Haycock JW, Wagner M, Morandini R, Ghanem G, Rennie IG, and Mac Neil S (1999) Alpha-melanocyte-stimulating hormone inhibits NF-κB activation in human melanocytes and melanoma cells, J Investig Dermatol 113:560-566.
166. Hedley SJ, Gawkrodger DJ, Weetman AP, Morandini R, Boeynaems JM, Ghanem G, and Neil SM (1998) α-Melanocyte stimulating hormone inhibits tumour necrosis factor-α stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol 138:536-543.
167. Heijmen PS, Klis SF, De Groot JC, and Smoorenburg GF (1999) Cisplatin ototoxicity and the possibly protective effect of α-melanocyte stimulating hormone. Hear Res 128:27-39.
168. Heinig JA, Keeley FW, Robson P, Sower SA, and Youson JH (1995) The appearance of proopiomelanocortin early in vertebrate evolution: cloning and sequencing of POMC from a Lamprey pituitary cDNA library. Gen Comp Endocrinol 99:137-144.
169. Herpin TF, Yu G, Carlson KE, Morton GC, Wu X, Kang L, Tuerdi H, Khanna A, Tokarski JS, Lawrence RM, and Macor JE (2003) Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. J Med Chem 46:1123-1126.
170. Hiltz ME, Catania A, and Lipton JM (1992) A-MSH peptides inhibit acute inflammation induced in mice by rIL-1 β, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 4:320-328.
171. Hiltz ME and Lipton JM (1989) Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide α-MSH. FASEB J 3:2282-2284.
172. Hiltz ME and Lipton JM (1990) Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11:979-982.
173. Hodgson DM, Yirmiya R, Chiappelli F, and Taylor AN (1998) Intracerebral HIV glycoprotein (gp120) enhances tumor metastasis via centrally released interleukin-1. Brain Res 781:244-251.
174. Hol EM, Sodaar P, and Bar PR (1994) Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspects. Ann NY Acad Sci 739:74-86.
175. Holdeman M, Khorram O, Samson WK, and Lipton JM (1985) Fever specific changes in MSH and CRF concentrations. Am J Physiol 248:R125-R129.
176. Holdeman M and Lipton JM (1985) Antipyretic activity of a potent α-MSH analog. Peptides 6:273-275.
177. Holder JR and Haskell-Luevano C (2003) Melanocortin tetrapeptides modified at the N-terminus, His, Phe, Arg and Trp positions. Ann NY Acad Sci 994:36-48.
178. Holder JR, Xiang Z, Bauzo RM, and Haskell-Luevano C (2002) Structure-activity relationships of the melanocortin tetrapeptide Ac-His Hyphendqq-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position. J Med Chem 45:5736-5744.
179. Hori T, Nakashima T, Take S, Kaizuka Y, Mori T, and Katafuchi T (1991) Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27:309-313.
180. Hruby VJ (2001) Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind-body problem. Acc Chem Res 34:389-397.
181. Hruby VJ and Han G (2000) The molecular pharmacology of α-MSH-structure-activity relationships for melanotropins at melanocortin receptors, in The Melanocortin Receptors (Cone RD ed), pp, 239-261, Humana Press, Totowa, NJ.
182. Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, al-Obeidi FA, Hadley ME, and Cone RD (1995) Cyclic lactam α-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7, Lys10] α-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 38:3454-3461.
183. Hruby VJ, Wilkes BC, Hadley ME, Al-Obeidi F, Sawyer TK, Staples DJ, de Vaux AE, Dym O, Castrucci AM, Hintz MF, et al. (1987) α-Melanotropin: the minimal active sequence in the frog skin bioassay. J Med Chem 30:2126-2130.
184. Huang Q and Tatro JB (2002) α-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in mice. Neurosci Lett 334:186-190.
185. Huang QH, Entwistle ML, Alvaro JD, Duman RS, Hruby VJ, and Tatro JB (1997) Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. J Neurosci 17:3343-3351.
186. Huang QH, Hruby VJ, and Tatro JB (1998) Systemic α-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am J Physiol 275:R524-R530.
187. Huh SK, Lipton JM, and Batjer HH (1997) The protective effects of α-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40:132-140.
188. Hunt G, Donatien PD, Lunec J, Todd C, Kyne S, and Thody AJ (1994) Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res 7:217-221.
189. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141.
190. Ichiyama T, Campbell IL, Furukawa S, Catania A, and Lipton JM (1999a) Autocrine α-melanocyte-stimulating hormone inhibits NF-κB activation in human glioma. J Neurosci Res 58:684-689.
191. Ichiyama T, Nishikawa M, Hayashi T, Hayashi S, Ryozawa M, and Furukawa S (2000a) Cerebrospinal fluid concentrations of α-melanocyte-stimulating hormone in bacterial and aseptic meningitis. Acta Paediatr 89:803-805.
192. Ichiyama T, Okada K, Campbell IL, Furukawa S, and Lipton JM (2000b) NF-κB activation is inhibited in human pulmonary epithelial cells transfected with α-melanocyte-stimulating hormone vector. Peptides 21:1473-1477.
193. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, and Lipton JM (1999b) Inhibition of peripheral NF-κB activation by central action of α-melanocyte-stimulating hormone. J Neuroimmunol 99:211-217.
194. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, and Lipton JM (1999c) Systemically administered α-melanocyte-stimulating peptides inhibit NF-κB activation in experimental brain inflammation. Brain Res 836:31-37.
195. Ichiyama T, Sato S, Okada K, Catania A, and Lipton JM (2000c) The neuroimmunomodulatory peptide α-MSH. Ann NY Acad Sci 917:221-226.
196. Ichiyama T, Zhao H, Catania A, Furukawa S, and Lipton JM (1999d) α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBa degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157:359-365.
197. Ignar DM, Andrews JL, Jansen M, Eilert MM, Pink HM, Lin P, Sherrill RG, Szewczyk JR, and Conway JG (2003) Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist. Peptides 24:709-716.
198. Jegou S, Boutelet I, and Vaudry H (2000) Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J Neuroendocrinol 12:501-505.
199. Jo SK, Yun SY, Chang KH, Cha DR, Cho WY, Kim HK, and Won NH (2001) α-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 16:1583-1591.
200. Joosten EA, Majewska B, Houweling DA, Bar PR, and Gispen WH (1999) Alpha-melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cord. J Neurotrauma 16:543-553.
201. Kalden DH, Scholzen T, Brzoska T, and Luger TA (1999) Mechanisms of the anti-inflammatory effects of α-MSH. Role of transcription factor NF-κB and adhesion molecule expression. Ann NY Acad Sci 885:254-261.
202. Kask A, Mutulis F, Muceniece R, Pahkla R, Mutule I, Wikberg JE, Rago L, and Schioth HB (1998) Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 139: 5006-5014.
203. Kavarana MJ, Trivedi D, Cai M, Ying J, Hammer M, Cabello C, Grieco P, Han G, and Hruby VJ (2002) Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. J Med Chem 45:2644-2650.
204. Kiss M, Kemeny L, Gyulai R, Michel G, Husz S, Kovacs R, Dobozy A, and Ruzicka T (1999) Effects of the neuropeptides substance P, calcitonin gene-related peptide and α-melanocyte-stimulating hormone on the IL-8/ IL-8 receptor system in a cultured human keratinocyte cell line and dermal fibroblasts. Inflammation 23: 557-567.
205. Klusa V, Svirskis S, Opmane B, Muceniece R, Skujins A, Mutulis F, Wikberg JE, and Schioth HB (1998) Evaluation of behavioural effects of neural melanocortin receptor antagonists injected ICV and in VTA in rats. Neuropeptides 32:573-580.
206. Konda Y, Gantz I, DelValle J, Shimoto Y, Miwa H, and Yamada T (1994) Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269:13162-13166.
207. Kraus J, Buchfelder M, and Holt V (1993) Regulatory elements of the human proopiomeIanocortin gene promotor. DNA Cell Biol 12:527-536.
208. Kwon TH, Frokiaer J, Fernandez-Llama P, Knepper MA, and Nielsen S (1999) Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: prevention by α-MSH. Am J Physiol 277:F413-F427.
209. Kwon TH, Frokiaer J, Han JS, Knepper MA, and Nielsen S (2000) Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol Renal Physiol 278:F925-F939.
210. Labbe O, Desarnaud F, Eggerickx D, Vassart G, and Parmentier M (1994) Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33:4543-4549.
211. Lankhorst AJ, Duis SE, ter Laak MP, Joosten EA, Hamers FP, and Gispen WH (1999) Functional recovery after central infusion of α -melanocyte-stimulating hormone in rats with spinal cord contusion injury. J Neurotrauma 16:323-331.
212. Lankhorst AJ, ter Laak MP, Hamers FP, and Gispen WH (2000) Combined treatment with αMSH and methylprednisolone fails to improve functional recovery after spinal injury in the rat. Brain Res 859:334-340.
213. Laquerriere A, Peulve P, Jin O, Tiollier J, Tardy M, Vaudry H, Hemet J, and Tadie M (1994) Effect of basic fibroblast growth factor and α-melanocytic stimulating hormone on nerve regeneration through a collagen channel. Microsurgery 15:203-210.
214. Lefkowitz RJ, Roth J, Pricer W, and Pastan I (1970) ACTH receptors in the adrenal: specific binding of ACTH-1251 and its relation to adenyl cyclase. Proc Natl Acad Sci USA 65:745-752.
215. Li CH and Chung D (1976) Primary structure of β-lipotropin. Nature (Lond) 260: 622-624.
216. Li SJ, Varga K, Archer P, Hruby VJ, Sharma SD, Kesterson RA, Cone RD, and Kunos G (1996) Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones. J Neurosci 16: 5182-5188.
217. Liakos P, Chambaz EM, Feige JJ, and Defaye G (1998) Expression of ACTH receptors (MC2-R and MC5-R) in the glomerulosa and the fasciculata-reticularis zones of bovine adrenal cortex. Endocr Res 24:427-432.
218. Lipton JM (1989) Neuropeptide α-melanocyte-stimulating hormone in control of fever, the acute phase response and inflammation, in Neuroimmune Networks: Physiology and Diseases (Goetzel E ed), pp 243-250, Alan R. Liss, Inc., New York.
219. Lipton JM and Catania A (1997) Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 18:140-145.
220. Lipton JM, Catania A, and Ichiyama T (2000) Marshaling the anti-inflammatory influence of the neuroimmunomodulator α-MSH. News Physiol Sci 15:192-195.
221. Lipton JM, Ceriani G, Macaluso A, McCoy D, Carnes K, Biltz J, and Catania A (1994) Antiinflammatory effects of the neuropeptide α-MSH in acute, chronic and systemic inflammation. Ann NY Acad Sci 741:137-148.
222. Lipton JM, Glyn JR, and Zimmer JA (1981) Hypothermic and antipyretic effects of centrally administered ACTH(1-24) and α-melanotropin. Fed Proc 40:2760-2762.
223. Lipton JM, Macaluso A, Hiltz ME, and Catania A (1991) Central administration of the peptide α-MSH inhibits inflammation in the skin. Peptides 12:795-798.
224. Lipton JM, Zhao H, Ichiyama T, Barsh GS, and Catania A (1999) Mechanisms of antiinflammatory action of α-MSH peptides. In vivo and in vitro evidence. Ann NY Acad Sci 885:173-182.
225. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, et al. (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature (Lond) 371:799-802.
226. Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkotter C, Armstrong C, and Ansel J (2000) The role of α-MSH as a modulator of cutaneous inflammation. Ann NY Acad Sci 917:232-238.
227. Luger TA, Kalden D, Scholzen TE, and Brzoska T (1999) α-Melanocyte-stimulating hormone as a mediator of tolerance induction. Pathobiology 67:318-321.
228. Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, and Paus R (1998) Cutaneous immunomodulation and coordination of skin stress responses by α-melanocyte-stimulating hormone. Ann NY Acad Sci 840:381-394.
229. Luger TA, Scholzen T, and Grabbe S (1997) The role of α-melanocyte-stimulating hormone in cutaneous biology. J Investig Dermatol Symp Proc 2:87-93.
230. Luger TA, Scholzen TE, Brzoska T, and Bohm M (2003) New insights into the functions of α-MSH and related peptides in the immune system. Ann NY Acad Sci 994:133-140.
231. Lyson K, Ceriani G, Takashima A, Catania A, and Lipton JM (1994) Binding of anti-inflammatory α-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation 1:121-126.
232. Macaluso A, McCoy D, Ceriani G, Watanabe T, Biltz J, Catania A, and Lipton JM (1994) Antiinflammatory influences of α-MSH molecules: central neurogenic and peripheral actions. J Neurosci 14:2377-2382.
233. MacNeil DJ, Howard AD, Guan X, Fong TM, Nargund RP, Bednarek MA, Goulet MT, Weinberg DH, Strack AM, Marsh DJ, et al. (2002) The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur J Pharmacol 440:141-157.
234. Magnoni S, Stocchetti N, Colombo G, Carlin A, Colombo A, Lipton JM, and Catania A (2003) α-Melanocyte stimulating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma 20:251-259.
235. Mains RE, Eipper BA, and Ling N (1977) Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 74:3014-3018.
236. Malide D, Seidah NG, Chretien M, and Bendayan M (1995) Electron microscopy immunocytochemical evidence for the involvment of the convertase PC1 and PC2 in the processing of proinsulin in pancreatic β-cells. J Histochem Cytochem 43:11-19.
237. Mandrika I, Muceniece R, and Wikberg JE (2001) Effects of melanocortin peptides on lipopolysaccharide/interferon-γ-induced NF-κB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol 61:613-621.
238. Manna SK and Aggarwal BB (1998) A-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J Immunol 161:2873-2880.
239. Marcinkiewicz M, Day R, Seidah NG, and Chretien M (1993) Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and α-melanotropin. Proc Natl Acad Sci USA 90:4922-4926.
240. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, and Palmiter RD (1999) Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21:119-122.
241. Martin LW, Catania A, Hiltz ME, and Lipton JM (1991) Neuropeptide α-MSH antagonizes IL-6- and TNF-induced fever. Peptides 12:297-299.
242. Martin LW, Deeter LB, and Lipton JM (1989) Acute-phase response to endogenous pyrogen in rabbit: effects of age and route of administration. Am J Physiol 257: R189-R193.
243. Martin LW and Lipton JM (1990a) Acute phase response to endotoxin: Rise in plasma α-MSH and effects of α-MSH injection. Am J Physiol 259:R768-R772.
244. Martin SA, Malkinson TJ, Veale WL, and Pittman QJ (1990) Depletion of brain α-MSH alters prostaglandin and interleukin fever in rats. Brain Res 526:351-354.
245. Mason MJ and Van Epps D (1989) Modulation of IL-1, tumor necrosis factor and C5a-mediated murine neutrophil migration by α-melanocyte-stimulating hormone. J Immunol 142:1646-1651.
246. May MJ and Ghosh S (1998) Signal transduction through NF-κB. Immunol Today 19:80-88.
247. Mazur AW, Kulesza A, Mishra RK, Cross-Doersen D, Russell AF, and Ebetino FH (2003) Novel tetrahydropyran-based peptidomimetics from a bioisosteric transformation of a tripeptide. Evidence of their activity at melanocortin receptors. Bioorg Med Chem 11:3053-3063.
248. Millington WR, Rosenthal DW, Unal CB, and Nyquist-Battie C (1999) Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart. Cardiovasc Res 43:107-116.
249. Mountjoy KG, Bird IM, Rainey WE, and Cone RD (1994a) ACTH induces upregulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol Cell Endocrinol 99:R17-R20.
250. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, and Cone RD (1994b) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308.
251. Mountjoy KG, Robbins LS, Mortrud MT, and Cone RD (1992) The cloning of a family of genes that encode the melanocortim receptors. Science (Wash DC) 257:1248-1251.
252. Moustafa M, Szabo M, Ghanem GE, Morandini R, Kemp EH, MacNeil S, and Haycock JW (2002) Inhibition of tumor necrosis factor-α stimulated NFKB/p65 in human keratinocytes by α-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Investig Dermatol 119:1244-1253.
253. Muceniece R, Krigere L, Suli-Vargha H, and Wikberg JE (2003) Effects of α-melanotropin C-terminal tripeptide analogues on macrophage NO production. Peptides 24:701-707.
254. Mugridge KG, Perretti M, Ghiara P, and Parente L (1991) Alpha-melanocyte-stimulating hormone reduces interleukin-1β effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197:151-155.
255. Murphy MT, Richards DB, and Lipton JM (1983) Antipyretic potency of centrally administered α-melanocyte stimulating hormone. Science (Wash DC) 221:192-193.
256. Nakanishi S, Inoue A, Kita. T, Nakamura M, Chang ACY, Cohen SN, and Numa S (1979) Nucleotide sequence of cloned cDNA for bovine corticotropin-β -lipotropin precursor. Nature (Lond) 278:423-427.
257. Neumann Andersen G, Nagaeva O, Mandrika I, Petrovska R, Muceniece R, Mincheva-Nilsson L, and Wikberg JE (2001) MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126:441-446.
258. Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, and Smith DH (1999) Prolonged activation of NF-κB following traumatic brain injury in rats. J Neurotrauma 16:1023-1034.
259. Noon LA, Franklin JM, King PJ, Goulding NJ, Hunyady L, and Clark AJ (2002) Failed export of the adrenocorticotrophin, receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. J Endocrinol 174:17-25.
260. Oktar BK, Ercan F, Yegen BC, and Alican I (2000) The effect of α-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21:1271-1277.
261. Ollmann MM, Lamoreux ML, Wilson BD, and Barsh GS (1998) Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev 12:316-330.
262. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, and Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science (Wash DC) 278:135-138.
263. Ono S, Date I, Onoda K, Shiota T, Ohmoto T, Ninomiya Y, Asari S, and Morishita R (1998) Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther 9:1003-1011.
264. Opp MR, Obal F, and Kreuger JM (1988) Effects of α-MSH on sleep, behavior and brain temperature: interactions with IL-1. Am J Physiol 255:R914-R922.
265. Peng PJ, Sahm UG, Doherty RV, Kinsman RG, Moss SH, and Pouton CW (1997) Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors. Peptides 18:1001-1008.
266. Penhoat A, Jaillard C, and Saez JM (1989) Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 86:4978-4981.
267. Plantinga LC, Verhaagen J, Edwards PM, Hali M, Brakkee JH, and Gispen WH (1995) Pharmacological evidence for the involvement of endogenous α-MSH-like peptides in peripheral nerve regeneration. Peptides 16:319-324.
268. Plantinga LC, Verhaagen J, Edwards PM, Schrama. LH, Burbach JP, and Gispen WH (1992) Expression of the pro-opiomelanocortin gene in dorsal root ganglia, spinal cord and sciatic nerve after sciatic nerve crush in the rat. Brain Res Mol Brain Res 16:135-142.
269. Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, and Ferreira SH (1992) Peripheral analgesic activities of peptides related to α-melanocyte stimulating hormone and interleukin-1β 193-195. Br J Pharmacol 106:489-492.
270. Pritchard LE, Turnbull AV, and White A (2002) Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172:411-421.
271. Prusis P, Muceniece R, Mutule I, Mutulis F, and Wikberg JE (2001) Design of new small cyclic melanocortin receptor-binding peptides using molecular modelling: role of the His residue in the melanocortin peptide core. Eur J Med Chem 36:137-146.
272. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, and Lipton JM (1997a) α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. J Neurosci 17:2181-2186.
273. Rajora N, Boccoli G, Catania A, and Lipton JM (1997b) α-MSH modulates experimental inflammatory bowel disease. Peptides 18:381-385.
274. Rajora N, Ceriani G, Catania A, Star RA, Murphy MT, and Lipton JM (1996) α-MSH production, receptors and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 59:248-253.
275. Rana BK (2003) New insights into G-protein-coupled receptor signaling from the melanocortin receptor system. Mol Pharmacol 64:1-4.
276. Ray DW, Ren SG, and Melmed S (1996) Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Investig 97:1852-1859.
277. Redondo P, Garcia-Foncillas J, Okroujnov I, and Bandres E (1998) Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 290:425-428.
278. Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Saunder DN, and Nordlund JJ (1989) Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Investig Dermatol 93:511-517.
279. Richards DB and Lipton JM (1984a) Antipyretic doses of α-MSH do not alter afebrile body temperature in the cold. J Thermal Biol 9:299-301.
280. Richards DB and Lipton JM (1984b) Effect of α-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides 5:815-817.
281. Roberts JL and Herbert E (1977) Characterization of a common precursor to corticotropin and β-lipotropin: cell free synthesis of the precursor and identification of corticotropin peptides in the molecule. Proc Natl Acad Sci USA 74:5300-5304.
282. Robertson B, Dostal K, and Daynes RA (1988) Neuropeptide regulation of inflammatory and immunologic responses. The capacity of α -melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol 140:4300-4307.
283. Robertson BA, Gahring LC, and Daynes RA (1986) Neuropeptide regulation of interleukin-1 activities. Capacity of α-melanocyte stimulating hormone to inhibit interleukin-1 inducible responses in vivo and in vitro exhibits target cell selectivity. Inflammation 10:371-385.
284. Rodbell M (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature (Lond) 284:17-22.
285. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatrc JB, Entwistle ML, Simerly RB, and Cone RD (1993) Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856-8860.
286. Rouillé Y, Duguay SJ, Lund K, Furuta M, Gong Q, Lipkind G, Oliva AA Jr, Chan SJ, and Steiner DF (1995) Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front Neuroendocrinol 16:322-361.
287. Sahm UG, Olivier GW, Branch SK, Moss SH, and Pouton CW (1994) Synthesis and biological evaluation of α-MSH analogues substituted with alanine. Peptides 15:1297-1302.
288. Salazar-Onfray F, Lopez M, Lundqvist A, Aguirre A, Escobar A, Serrano A, Korenblit C, Petersson M, Chhajlani V, Larsson O, and Kiessling R (2002) Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer 87:414-422.
289. Samson WK, Lipton JM, and Zimmer JA (1981) The effect of fever on central α-MSH concentrations in the rabbit. Peptides 2:419-423.
290. San T, Oktar BK, Salik E, Ercan F, and Alican I (2001) The effect of α-melanocyte stimulating hormone on endotoxin-induced intestinal injury. Peptides 22:2077-2082.
291. Sarkar S, Legradi G, and Lechan RM (2002) Intracerebroventricular administration of α-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus. Brain Res 945:50-59.
292. Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB, and Hadley ME (1980) 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 77:5754-5758.
293. Schioth HB, Muceniece R, Mutulis F, Prusis P, Lindeberg G, Sharma SD, Hruby VJ, and Wikberg JE (1997a) Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides 18:1009-1013.
294. Schioth HB, Muceniece R, and Wikberg JE (1997b) Selectivity of [Phe-I7], [Ala6] and [D-Ala4, Gln5, Tyr6] substituted ACTH(4-10) analogues for the melanocortin receptors. Peptides 18:761-763.
295. Schioth HB, Mutulis F, Muceniece R, Prusis P, and Wikberg JE (1998) Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes. Eur J Pharmacol 349:359-366.
296. Schioth HB, Tesfaye A, Mutulis F, Rudzish R, Mutule I, Muceniece R, Watanobe H, and Wikberg JE (2002) Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues. Neuropeptides 36:427-434.
297. Scholzen TE, Brzoska T, Kalden DH, Hartmeyer M, Fastrich M, Luger TA, Armstrong CA, and Ansel JC (1999) Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells. Ann NY Acad Sci 885:239-253.
298. Scholzen TE, Sunderkotter C, Kalden DH, Brzoska T, Fastrich M, Fisbeck T, Armstrong CA, Ansel JC, and Luger TA (2003) α-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144:360-370.
299. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Bum P, and Baskin DG (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123.
300. Scott MC, Suzuki I, and Abdel-Malek ZA (2002) Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res 15:433-439.
301. Seechurn P, Burchill SA, and Thody AJ (1988) Effect of α-melanocyte-stimulating hormone on tyrosinase activity in hair follicular and epidermal melanocytes of the mouse. J Endocrinol 119:517-522.
302. Seidah NG, Benjannet S, Hamelin J, Mamarbachi AM, Basak A, Marcinkiewicz J, Mbikay M, Chretien M, and Marcinkiewicz M (1999) The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann NY Acad Sci 885:57-74.
303. Seidah NG and Chretien M (1994) Pro-protein convertases of subtilisin/kexin family. Methods Enzymol 244:175-188.
304. Seidah NG, Day R, Hamelin J, Gaspar A, Collard MW, and Chretien M (1992) Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase. Mol Endocrinol 6:1559-1570.
305. Seidah NG, Day R, Marcinkiewicz M, Benjannet S, and Chretien M (1991) Mammalian neural and endocrine pro-protein and pro-hormone convertases belonging to the subtilisin family of serine proteinases. Enzyme (Basel) 45:271-284.
306. Seidah NG, Hamelin J, Mamarbachi M, Dong W, Tardos H, Mbikay M, Chretien M, and Day R (1996) cDNA structure, tissue distribution and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexinlike proteinases. Proc Natl Acad Sci USA 93:3388-3393.
307. Shih ST, Khorram O, Lipton JM, and McCann SM (1986) Central administration of α-MSH antiserum augments fever in the rabbit. Am J Physiol 250:R803-R806.
308. Skottner A, Post C, Ocklind A, Seifert E, Liutkevicius E, Meskys R, Pilinkiene A, Biziuleviciene G, and Lundstedt T (2003) Anti-inflammatory potential of melanocortin receptor-directed drugs. Ann NY Acad Sci 994:84-89.
309. Slominski A and Pawelek J (1998) Animals under the sun: effects of ultraviolet radiation on mammalian skin. Clin Dermatol 16:503-515.
310. Slominski A and Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21:457-487.
311. Slominski A, Wortsman J, Luger T, Paus R, and Solomon S (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020.
312. Smith AG, Box NF, Marks LH, Chen W, Smit DJ, Wyeth JR, Huttley GA, Easteal S, and Sturm RA (2001) The human melanocortin-1 receptor locus: analysis of transcription unit, locus polymorphism and haplotype evolution. Gene 281:81-94.
313. Smolnik R, Perras B, Molle M, Fehm HL, and Born J (2000) Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-α-melanocyte stimulating hormone. J Clin Psychopharmacol 20:445-454.
314. Star RA, Rajora N, Huang J, Stock RC, Catania A, and Lipton JM (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92:8016-8020.
315. Starowicz K and Przewlocka B (2003) The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci 73:823-847.
316. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, and Palmiter RD (2000) A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 97:12339-12344.
317. Strand FL and Kung TT (1980) ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve. Peptides 1:135-138.
318. Strand FL, Lee SJ, Lee TS, Zuccarelli LA, Antonawich FJ, Kume J, and Williams KA (1993) Non-corticotropic ACTH peptides modulate nerve development and regeneration. Rev Neurosci 4:321-363.
319. Strand FL, Rose KJ, King JA, Segarra AC, and Zuccarelli LA (1989) ACTH modulation of nerve development and regeneration. Prog Neurobiol (Oxford) 33:45-85.
320. Strand FL, Williams KA, Alves SE, Antonawich FJ, Lee TS, Lee SJ, Kume J, and Zuccarelli LA (1994) Melanocortins as factors in somatic neuromuscular growth and regrowth. Pharmacol Ther 62:1-27.
321. Sundar SK, Becker KJ, Cierpial MA, Carpenter MD, Rankin LA, Fleener SL, Ritchie JC, Simson PE, and Weiss JM (1989) Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 86:6398-6402.
322. Sundar SK, Cierpial MA, Kamaraju LS, Long S, Hsieh S, Lorenz C, Aaron M, Ritchie JC, and Weiss JM (1991) Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci USA 88:11246-11250.
323. Suzuki I, Cone RD, Im S, Nordlund J, and Abdel-Malek ZA (1996) Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137:1627-1633.
324. Szardenings M, Muceniece R, Mutule I, Mutulis F, and Wikberg JE (2000) New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 21:239-243.
325. Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, Kelly L, Zhao H, Ichiyama T, Catania A, and Lipton JM (1999) α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. Am J Physiol 276:R1289-R1294.
326. Tatro JB and Sinha PS (2003) The central melanocortin system and Fever. Ann NY Acad Sci 994:246-257.
327. Taylor A and Namba K (2001) In vitro induction of CD25 + CD4+ regulatory T cells by the neuropeptide α-melanocyte stimulating hormone (α-MSH). Immunol Cell Biol 79:358-367.
328. Taylor AW, Yee DG, Nishida T, and Namba K (2000) Neuropeptide regulation of unity immunity. The immunosuppressive activity of α -melanocyte-stimulating hormone (α-MSH). Ann NY Acad Sci 917:239-247.
329. Ter Laak MP, Brakkee JH, Adan RA, Hamers FP, and Gispen WH (2003) The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat. Eur J Pharmacol 462:179-183.
330. Thody AJ (1999) α-MSH and the regulation of melanocyte function. Ann NY Acad Sci 885:217-229.
331. Thody AJ, Ridley K, Penny RJ, Chalmers R, Fisher C, and Shuster S (1983) MSH peptides are present in mammalian skin. Peptides 4:813-816.
332. Thody AJ and Shuster S (1970) The pituitary and sebaceous gland activity. J Endocrinol 48:139-140.
333. Thody AJ and Shuster S (1975) Control of sebaceous gland function in the rat by α-melanocyte-stimulating hormone. J Endocrinol 64:503-510.
334. Tsatmali M, Graham A, Szatkowski D, Ancans J, Manning P, McNeil CJ, Graham AM, and Thody AJ (2000) α-melanocyte-stimulating hormone modulates nitric oxide production in melanocytes. J Investig Dermatol 114:520-526.
335. Uehara Y, Shimizu H, Sato N, Tanaka Y, Shimomura Y, and Mori M (1992) Carboxyl-terminal tripeptide of α-melanocyte-stimulating hormone antagonizes interleukin-1-induced anorexia. Eur J Pharmacol 220:119-122.
336. van de Meent H, Hamers FP, Lankhorst AJ, Joosten EA, and Gispen WH (1997) Beneficial effects of the melanocortin α-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery 40:122-131.
337. van der Hoop RG, Vecht CJ, van der Burg ME, Elderson A, Boogerd W, Heimans JJ, Vries EP, van Houwelingen JC, Jennekens FG, Gispen WH, et al. (1990) Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med 322:89-94.
338. van der Kraan M, Adan RA, Entwistle ML, Gispen WH, Burbach JP, and Tatro JB (1998) Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139:2348-2355.
339. van der Kraan M, Tatro JB, Entwistle ML, Brakkee JH, Burbach JP, Adan RA, and Gispen WH (1999) Expression of melanocortin receptors and pro-opiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins. Brain Res Mol Brain Res 63:276-286.
340. Van der Neut R, Bar PR, Sodaar P, and Gispen WH (1988) Trophic influences of α-MSH and ACTH4-10 on neuronal outgrowth in vitro. Peptides 9:1015-1020.
341. van der Neut R, Hol EM, Gispen WH, and Bar PR (1992) Stimulation by melanocortins of neurite outgrowth from spinal and sensory neurons in vitro. Peptides 13:1109-1115.
342. Van der Ploeg LH, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, et al. (2002) A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99:11381-11386.
343. Van der Zee CE, Brakkee JH, and Gispen WH (1988) α-MSH and Org. 2766 in peripheral nerve regeneration: different routes of delivery. Eur J Pharmacol 147:351-357.
344. Van der Zee CE, Van der Hoop RG, and Gispen WH (1989) Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats. Diabetes 38:225-230.
345. van Gerven JM, Hovestadt A, Moll JW, Rodenburg CJ, Splinter TA, van Oosterom AT, Keizer L, Drogendijk TE, Groenhout CM, Vecht CJ, et al. (1994) The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial. J Neurol 241:432-435.
346. Verhaagen J, Edwards PM, Jennekens FG, Schotman P, and Gispen WH (1987) Early effect of an ACTH4-9 analog (Org.2766) on regenerative sprouting demonstrated by the use of neurofilament-binding antibodies isolated from a serum raised by α-MSH immunization. Brain Res 404:142-150.
347. Villar M, Perassi N, and Celis ME (1991) Central and peripheral actions of α-MSH in the thermoregulation of rats. Peptides 12:1441-1443.
348. Voisey J and van Daal A (2002) Agouti: from mouse to man, from skin to fat. Pigment Cell Res 15:10-18.
349. Wakamatsu K, Graham A, Cook D, and Thody AJ (1997) Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res 10:288-297.
350. Watanabe T, Hiltz ME, Catania A, and Lipton JM (1993) Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. Brain Res Bull 32:311-314.
351. Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, and Levine N (1998) Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol 160: 389-393.
352. Wessells H, Gralnek D, Dorr R, Hruby VJ, Hadley ME, and Levine N (2000) Effect of an α-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 56:641-646.
353. Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, and Skottner A (2000) New aspects on the melanocortins and their receptors. Pharmacol Res 42:393-420.
354. Wikberg JE, Mutulis F, Mutule I, Veiksina S, Lapinsh M, Petrovska R, and Prusis P (2003) Melanocortin receptors: ligands and proteochemometrics modeling. Ann NY Acad Sci 994:21-26.
355. Willard DH, Bodnar W, Harris C, Kiefer L, Nichols JS, Blanchard S, Hoffman C, Moyer M, Burkhart W, Weiel J, et al. (1995) Agouti structure and function: characterization of a potent α-melanocyte stimulating hormone receptor antagonist. Biochemistry 34:12341-12346.
356. Wilson BD, Ollmann MM, and Barsh GS (1999) The role of agouti-related protein in regulating body weight. Mol Med Today 5:250-256.
357. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, and Barsh GS (1995) Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 4:223-230.
358. Wirth MM and Giraudo SQ (2000) Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding. Peptides 21:1369-1375.
359. Wong KY, Rajora N, Boccoli G, Catania A, and Lipton JM (1997) A potential mechanism of local anti-inflammatory action of α -melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-α production by human astrocytic cells. Neuroimmunomodulation 4:37-41.
360. Xia Y and Wikberg JE (1996) Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell Tissue Res 286:63-68.
361. Xia Y, Wikberg JE, and Chhajlani V (1995) Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 6:2193-2196.
362. Yang Y, Dickinson C, Haskell-Luevano C, and Gantz I (1997) Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor. J Biol Chem 272:23000-23010.
363. Zimmer JA and Lipton JM (1981) Central and peripheral injections of ACTH (1-24) reduce fever in adrenalectomized rabbits. Peptides 2:419-423.